{{Rsnum
|rsid=12746200
|Gene=PLA2G4A
|Chromosome=1
|position=186880054
|Orientation=plus
|GMAF=0.06703
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=PLA2G4A
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 84.1 | 15.9 | 0.0
| HCB | 93.4 | 6.6 | 0.0
| JPT | 81.4 | 15.0 | 3.5
| YRI | 100.0 | 0.0 | 0.0
| ASW | 94.7 | 5.3 | 0.0
| CHB | 93.4 | 6.6 | 0.0
| CHD | 91.7 | 7.3 | 0.9
| GIH | 80.2 | 17.8 | 2.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 77.6 | 22.4 | 0.0
| MKK | 89.7 | 10.3 | 0.0
| TSI | 81.4 | 18.6 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19795129
|Title=Impact of group IVA cytosolic phospholipase A2 gene polymorphisms on phenotypic features of patients with familial adenomatous polyposis
}}

{{PMID Auto
|PMID=21293878
|Title=Genetic contribution of the leukotriene pathway to coronary artery disease
|OA=1
}}

{{PMID|22378731|OA=1
}} Association of PLA2G4A with myocardial infarction is modulated by dietary PUFAs.

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}